selective inhibition of the tumor-associated carbonic anhydrase
isoforms IX and XII, Organic & biomolecular chemistry, 13 (2015)
6493-6499.
[18] A. Akdemir, O. Guzel-Akdemir, A. Scozzafava, C. Capasso,
C.T. Supuran, Inhibition of tumor-associated human carbonic
anhydrase isozymes IX and XII by a new class of substituted-
phenylacetamido aromatic sulfonamides, Bioorganic & medicinal
chemistry, 21 (2013) 5228-5232.
Acknowledgments
This project was in part financed by the “Istanbul University
Scientific Research Projects Department” (project number: UDP-
32911).
References and notes
[19] A. Akdemir, C. De Monte, S. Carradori, C.T. Supuran,
Computational investigation of the selectivity of salen and
tetrahydrosalen compounds towards the tumor-associated hCA XII
isozyme, Journal of enzyme inhibition and medicinal chemistry, 30
(2015) 114-118.
[1] C.T. Supuran, Carbonic anhydrase inhibitors, Bioorganic &
medicinal chemistry letters, 20 (2010) 3467-3474.
[2] E.G. Mogensen, G. Janbon, J. Chaloupka, C. Steegborn, M.S. Fu,
F. Moyrand, T. Klengel, D.S. Pearson, M.A. Geeves, J. Buck, L.R.
Levin, F.A. Muhlschlegel, Cryptococcus neoformans senses CO2
through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1,
Eukaryotic cell, 5 (2006) 103-111.
[3] Y.S. Bahn, F.A. Muhlschlegel, CO2 sensing in fungi and beyond,
Current opinion in microbiology, 9 (2006) 572-578.
[4] T. Klengel, W.J. Liang, J. Chaloupka, C. Ruoff, K. Schroppel,
J.R. Naglik, S.E. Eckert, E.G. Mogensen, K. Haynes, M.F. Tuite,
L.R. Levin, J. Buck, F.A. Muhlschlegel, Fungal adenylyl cyclase
integrates CO2 sensing with cAMP signaling and virulence, Current
biology : CB, 15 (2005) 2021-2026.
[5] Y.S. Bahn, G.M. Cox, J.R. Perfect, J. Heitman, Carbonic
anhydrase and CO2 sensing during Cryptococcus neoformans
growth, differentiation, and virulence, Current biology : CB, 15
(2005) 2013-2020.
[6] C.T. Supuran, Carbonic anhydrases: novel therapeutic
applications for inhibitors and activators, Nature reviews. Drug
discovery, 7 (2008) 168-181.
[7] C.T. Supuran, C. Capasso, The eta-class carbonic anhydrases as
drug targets for antimalarial agents, Expert opinion on therapeutic
targets, 19 (2015) 551-563.
[8] A. Scozzafava, C.T. Supuran, F. Carta, Antiobesity carbonic
anhydrase inhibitors: a literature and patent review, Expert opinion
on therapeutic patents, 23 (2013) 725-735.
[9] F. Carta, C.T. Supuran, Diuretics with carbonic anhydrase
inhibitory action: a patent and literature review (2005 - 2013), Expert
opinion on therapeutic patents, 23 (2013) 681-691.
[10] C. Capasso, C.T. Supuran, Anti-infective carbonic anhydrase
inhibitors: a patent and literature review, Expert opinion on
therapeutic patents, 23 (2013) 693-704.
[11] S.M. Monti, C.T. Supuran, G. De Simone, Carbonic anhydrase
IX as a target for designing novel anticancer drugs, Current
medicinal chemistry, 19 (2012) 821-830.
[12] P.C. McDonald, J.Y. Winum, C.T. Supuran, S. Dedhar, Recent
developments in targeting carbonic anhydrase IX for cancer
therapeutics, Oncotarget, 3 (2012) 84-97.
[13] G. De Simone, C.T. Supuran, Antiobesity carbonic anhydrase
inhibitors, Current topics in medicinal chemistry, 7 (2007) 879-884.
[14] D. Vullo, W. Leewattanapasuk, F.A. Muhlschlegel, A.
Mastrolorenzo, C. Capasso, C.T. Supuran, Carbonic anhydrase
inhibitors: inhibition of the beta-class enzyme from the pathogenic
yeast Candida glabrata with sulfonamides, sulfamates and
sulfamides, Bioorganic & medicinal chemistry letters, 23 (2013)
2647-2652.
[15] F. Cottier, W. Leewattanapasuk, L.R. Kemp, M. Murphy, C.T.
Supuran, O. Kurzai, F.A. Muhlschlegel, Carbonic anhydrase
regulation and CO(2) sensing in the fungal pathogen Candida
glabrata involves a novel Rca1p ortholog, Bioorganic & medicinal
chemistry, 21 (2013) 1549-1554.
[16] S.M. Monti, A. Maresca, F. Viparelli, F. Carta, G. De Simone,
F.A. Muhlschlegel, A. Scozzafava, C.T. Supuran, Dithiocarbamates
are strong inhibitors of the beta-class fungal carbonic anhydrases
from Cryptococcus neoformans, Candida albicans and Candida
glabrata, Bioorganic & medicinal chemistry letters, 22 (2012) 859-
862.
[17] O. Guzel-Akdemir, A. Akdemir, N. Karali, C.T. Supuran,
Discovery of novel isatin-based sulfonamides with potent and